Detect drug induced liver injury (DILI) early in the drug discovery process with 爱游戏平台注册登录 's IVISense™ Toxicology Fluorescent Imaging Panel.
Drug-induced liver injury (DILI) is the leading reason for termination of drug discovery research projects and is a significant concern in attrition of new drug molecules reaching phase III clinical trials. DILI can manifest in hepatocellular, cholestatic, and steatotic forms differing in the type and pattern of tissue injury, biomarker expression and inflammation in the liver lobules.
For research use only. Not for use in diagnostic procedures.
false false
Our Toxicology Fluorescent Imaging Panel of probes allows you to image inflammation, tissue destruction, metabolic changes, and vascular leak (edema), in a manner that can be predictive of potential drug toxicity, measuring biological changes prior to overt histological signs. Our published research shows the utility of a three-probe cocktail for imaging drug-induced liver injury (Vasquez & Peterson, J Pharmacol Exp Ther 2017; 361:87-98) via a ratio of probes specifically designed to optimize liver injury signal while minimizing normal background signal in liver and kidneys. The Toxicology Panel provides an extra vial of IVISense MMP 750 FAST to allow the preparation of the cocktail.
The inclusion of probes at 680 nm and 750 nm wavelengths further offers the opportunity for multiplex imaging of appropriate probe combinations to maximize information gained from research animals.
Our IVISense Toxicology Fluorescent Imaging Panel includes the following five probes (6 vials):
| Part Number | Fluorescent Probe | Biological Target |
|---|---|---|
| NEV10054EX | IVISense Vascular 680 (AngioSense 680EX) | Vascular probe: Leaks into sites of vascular damage or inflammation |
| NEV10091 | IVISense Transferrin Receptor 750 (Transferrin-Vivo 750) | Transferrin receptor targeted probe: Iron metabolism marker in liver |
| NEV10168 x 2 | IVISense MMP 750 FAST (MMPSense 750 FAST) | Pan-MMP activatable probe: Secreted marker of stellate cells, Kupffer cells, macrophages, and neutrophils |
| NEV11053 | IVISense Annexin-V 750 Fluorescent Probe (Annexin-Vivo) | Death/apoptosis probe: Marker on inflammatory cells; metabolic marker on tumor cells |
| NEV11079 | IVISense Renin 680 FAST (ReninSense 680 FAST) | Renin activatable probe: Marker of tissue renin-angiotensin system activity |
| 光學成像分類 | Fluorescence Imaging |
|---|---|
| 產品品牌名稱 | IVISense |
| 包裝量 | 6.0 Vials |
| 運輸條件 | 藍冰 |
| 治療領域 | Toxicology |
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And ...
Our comprehensive range of bioluminescent and fluorescent imaging reagents provide researchers with the necessary tools to better understand early disease-related biological changes, track disease progression, help guide the drug discovery process, and evaluate efficacy and safety of drug candida ...
Data sheet on 爱游戏平台注册登录 's Fluorescent Panels for In Vivo imaging
Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into disease processes and treatment effects. Designing an effective study from the beginning can help save time and resources.
Learn about several important best p ...
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.
This s ...
User guide for fluorescent imaging probes
The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick ...
